Juan N. Liu

7 Science Park Road
Beijing, 102206, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Spatial multi-omics identifies a NOTCH3-mediated capillary-mCAF crosstalk driving immune exclusion in hepatocellular carcinoma.

Spatial multi-omics identifies a NOTCH3-mediated capillary-mCAF crosstalk driving immune exclusion in hepatocellular carcinoma.

Journal: iMeta

Published: January 29, 2026

Glutathione-activatable bola dendrimers mediate tumor-specific cytosolic siRNA delivery via dynamic thiol-disulfide exchange.

Glutathione-activatable bola dendrimers mediate tumor-specific cytosolic siRNA delivery via dynamic thiol-disulfide exchange.

Journal: Biomaterials science

Published: January 26, 2026

From bioinks to living matter: bioprinting enters the "pure cell" era.

From bioinks to living matter: bioprinting enters the "pure cell" era.

Journal: Science bulletin

Published: January 04, 2026

NUPR1 as a central stress-adaptation node in cancer: integrating metabolic rewiring, cell death, and therapy resistance.

NUPR1 as a central stress-adaptation node in cancer: integrating metabolic rewiring, cell death, and therapy resistance.

Journal: Journal of biomedical science

Published: November 21, 2025

Dual-functional nanovesicles simultaneously inhibit stromal fibrosis and angiogenesis to suppress cholangiocarcinoma progression.

Dual-functional nanovesicles simultaneously inhibit stromal fibrosis and angiogenesis to suppress cholangiocarcinoma progression.

Journal: Journal of nanobiotechnology

Published: July 16, 2025

mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics.

mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics.

Journal: Cancer innovation

Published: July 14, 2025

Engineered immune-driven theranostics for clinical cardiology.

Engineered immune-driven theranostics for clinical cardiology.

Journal: Military Medical Research

Published: July 01, 2025

Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy.

Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy.

Journal: Science advances

Published: June 25, 2025

Nucleic acid therapeutics for liver diseases: A decade of technological convergence and clinical challenges.

Nucleic acid therapeutics for liver diseases: A decade of technological convergence and clinical challenges.

Journal: iLIVER

Published: April 28, 2025

Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms.

Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms.

Journal: Cancer letters

Published: March 18, 2025

Molecular Dissection of the AHR-AREG driven EGFR-ERK1/2-CyclinD1 axis in acquired lenvatinib resistance of Hepatocellular carcinoma.

Molecular Dissection of the AHR-AREG driven EGFR-ERK1/2-CyclinD1 axis in acquired lenvatinib resistance of Hepatocellular carcinoma.

Journal: Biochemical pharmacology

Published: February 22, 2025

Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma.

Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma.

Journal: Signal transduction and targeted therapy

Published: February 12, 2025

Showing 1-12 of 42

Last Updated: 09/26/2026